Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Oragenics Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 16 | 19 | +3 |
| Shares | 122.5K | 216.1K | +93.6K (+76.4%) |
| Value | $160.5K | $169.3K | +$8.74K (+5.4%) |
New holders (5)
Institutions that held Oragenics Inc at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 33,747 | $26.4K | 0.00% |
| Huntington National Bank | 3 | $2 | 0.00% |
| Adkins Seale Capital Management LLC | 3 | $2 | 0.00% |
| Root Financial Partners, LLC | 1 | $1 | 0.00% |
| Motiv8 Investments LLC | 1 | $0 | 0.00% |
Sold out (2)
Institutions that held Oragenics Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Allworth Financial LP | 334 | $438 |
| Evermay Wealth Management LLC | 1 | $2 |